NT-101 Topical Ophthalmic Solution

NT-101 · NexThera Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NT-101 Topical Ophthalmic Solution, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: NT-101 Topical Ophthalmic Solution in Patients With Wet AMD [Phase 1, Phase 2]